Product Information

CLINDAMYC-BNZ PEROX 1.2-3.75% is a generic product labeled by Mayne Pharma, priced at $2.0858 per GM under NDC 68308012750. Its NADAC has been published 39 times since Feb 25, 2026.

FDA first approved this application on Aug 20, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYC-BNZ PEROX 1.2-3.75%

Clindamycin Phosphate and Benzoyl Peroxide
$2.0858per GM

Strength

37.5; 10 mg/g; mg/g

Manufacturer

Mayne Pharma

NDC

68308012750

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209610

FDA Approved

8/20/2024

TE Code

AB

On Market Since

10/1/2025

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has been published 39 times since Feb 25, 2026, and over the history we have for it it has declined 49.0%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0858 per GM
All-time high$4.0918 (Mar 11, 2026)
All-time low$2.0858 (Nov 18, 2026)
52-week high$4.0918
52-week low$2.0858
Median price$2.4677
Average price$2.6567
Largest weekly change-22.2% (Apr 22, 2026)
Weeks tracked39
Tracking sinceFeb 25, 2026

Price History

1W

-4.3%

1M

-11.0%

3M

-15.6%

6M

-14.8%

1Y

N/A

3Y

N/A

5Y

N/A

All

-49.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYC-BNZ PEROX 1.2-3.75%?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYC-BNZ PEROX 1.2-3.75%, manufactured by Mayne Pharma, is $2.0858 per GM (NDC 68308012750), effective Nov 18, 2026.

How has the price of CLINDAMYC-BNZ PEROX 1.2-3.75% changed over time?

Over the history we have for it, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has declined 49.0%. It has been tracked across 39 weekly CMS publications since Feb 25, 2026.

What are the highest and lowest recorded NADAC prices for CLINDAMYC-BNZ PEROX 1.2-3.75%?

Since Feb 25, 2026, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has ranged from a low of $2.0858 (Nov 18, 2026) to a high of $4.0918 (Mar 11, 2026), with a median of $2.4677 per GM.

Are there cheaper alternatives to CLINDAMYC-BNZ PEROX 1.2-3.75%?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLINDAMYC-BNZ PEROX 1.2-3.75% in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDAMYC-BNZ PEROX 1.2-3.75%?

CLINDAMYC-BNZ PEROX 1.2-3.75% (NDC 68308012750) is labeled by Mayne Pharma, and CMS classifies it as a generic product.